Yearly Archives - 2019

Botanix Pharmaceuticals (ASX:BOT) clinical trial update

16 Dec 2019 - Botanix Pharmaceuticals Limited (ASX:BOT) Founder Matthew Callahan talks about the company's Phase 2 US trial results for severe acne, plans for its Phase 3 trails, including FDA input, its Phase 2 atopic dermatitis study, and what investors can expect over the next 6 months.

Read more...

UK election boosts the Australian market: ASX closed 0.5% higher

13 Dec 2019 - It has been a positive day of trade for the Australian share market the local bourse managed to close 0.5% higher. Stocks with significant UK businesses enjoyed gains such as Virgin Money UK (ASX:VUK) after exit polls in the UK election point to a Boris Johnson majority. Adairs (ASX:ADH) has today completed its acquisition of Mocka.

Read more...